Role of Yogic Asanas in the Management of Abdominal Obesity and Non-Alcoholic Fatty Liver Disease: A Narrative Review
Keywords:
Yoga, Asanas, Abdominal Obesity, Fatty Liver, NAFLD, Metabolic Syndrome.Abstract
Background:
Abdominal obesity and Non-Alcoholic Fatty Liver Disease are increasingly prevalent metabolic disorders associated with sedentary lifestyles and unhealthy dietary habits. Visceral fat accumulation plays a central role in the development of insulin resistance, dyslipidemia, and hepatic steatosis. Conventional management strategies often face limitations in long-term adherence, highlighting the need for sustainable lifestyle interventions.
Objective:
This narrative review aims to evaluate the role of yogic asanas in reducing abdominal obesity and improving fatty liver disease, with a focus on underlying mechanisms and available clinical evidence.
Methods:
A comprehensive literature review was conducted using published studies on yoga, obesity, and fatty liver disease. Relevant clinical trials, observational studies, and review articles were analyzed to assess the effects of specific yogic asanas and integrated yoga practices on metabolic and hepatic parameters.
Results:
Yogic asanas such as Pavanamuktasana, Bhujangasana, Dhanurasana, and Naukasana demonstrate significant potential in reducing abdominal fat by enhancing core muscle activity, improving digestion, and increasing metabolic rate. These practices also contribute to improved insulin sensitivity, reduced stress hormone levels, and better lipid metabolism. Clinical studies indicate reductions in body mass index, waist circumference, and liver enzyme levels (ALT, AST) following regular yoga practice. Additionally, integrated approaches including pranayama and meditation further enhance these benefits through modulation of the autonomic nervous system and reduction of oxidative stress.
Conclusion:
Yoga offers a holistic and effective complementary approach for the management of abdominal obesity and fatty liver disease. Its combined effects on physical, metabolic, and psychological parameters make it a promising non-pharmacological intervention. However, further large-scale, well-designed clinical trials are needed to establish standardized protocols and strengthen the evidence base.
References
1. World Health Organization. Obesity and overweight. Geneva: WHO; 2021.
2. Cramer H, et al. Yoga for metabolic syndrome: A systematic review. Evid Based Complement Alternat Med. 2016;2016:1-12.
3. Després JP. Body fat distribution and risk. Circulation. 2012;126:1301–13.
4. Younossi ZM, et al. Global epidemiology of NAFLD. Hepatology. 2016;64:73–84.
5. Fabbrini E, et al. Obesity and NAFLD link. Hepatology. 2010;51:679–89.
6. Ross A, Thomas S. Yoga and health benefits. J Altern Complement Med. 2010;16:3–12.
7. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860–7.
8. Samuel VT, Shulman GI. Insulin resistance. J Clin Invest. 2016;126:12–22.
9. Sanyal AJ. Mechanisms of NAFLD. Gastroenterology. 2010;138:1490–500.
10. Tilg H, Moschen AR. Gut-liver axis. Hepatology. 2010;52:1836–46.
11. Field T. Yoga clinical research. Complement Ther Clin Pract. 2011;17:1–8.
12. Streeter CC, et al. Yoga and autonomic system. Med Hypotheses. 2012;78:571–9.
13. Innes KE, et al. Yoga and metabolic risk. Evid Based Complement Alternat Med. 2005;2:273–85.
14. Woodyard C. Yoga and health. J Yoga Phys Ther. 2011;1:101.
15. Saraswati SS. Asana Pranayama Mudra Bandha. Bihar: Yoga Publications; 2008.
16. Iyengar BKS. Light on Yoga. London: HarperCollins; 1991.
17. Telles S, et al. Yoga for obesity. Indian J Med Res. 2013;137:123–9.
18. Tran MD, et al. Effects of yoga training. Prev Cardiol. 2001;4:165–70.
19. Gupta N, et al. Yoga and liver function. J Clin Diagn Res. 2012;6:1–5.
20. Nagarathna R, Nagendra HR. Yoga for liver disorders. J Altern Complement Med. 2009;15:1–7.
21. Sharma M. Yoga and metabolic syndrome. J Clin Med. 2014;3:1–10.
22. Kiecolt-Glaser JK. Stress and inflammation. Nat Rev Immunol. 2015;15:1–9.
23. Cohen BE, et al. Yoga and obesity trial. Am J Prev Med. 2016;50:1–9.
24. Rathi S, et al. Yoga in NAFLD patients. J Clin Exp Hepatol. 2017;7:1–6.
25. Hartley L, et al. Yoga for cardiovascular risk. Cochrane Database. 2014;5:CD010072.
26. Sherman KJ. Guidelines for yoga research. Ann Intern Med. 2013;159:569–70.
27. Brown RP, Gerbarg PL. Sudarshan Kriya effects. J Altern Complement Med. 2005;11:189–201.
28. Kabat-Zinn J. Mindfulness research. Clin Psychol Sci Pract. 2003;10:144–56.
29. Satyananda S. Yogic diet principles. Bihar School of Yoga; 2005.
30. Kirkwood G, et al. Yoga for anxiety. Br J Sports Med. 2005;39:884–91.
31. Ross A. Yoga mechanisms. Holist Nurs Pract. 2012;26:1–10.
32. Büssing A, et al. Yoga research challenges. Evid Based Complement Alternat Med. 2012;2012:1–7.
33. Gard T, et al. Future yoga research. Front Psychiatry. 2014;5:1–8.
34. Pascoe MC, Bauer IE. Yoga and brain health. Brain Plast. 2015;1:1–12.
35. Larkey LK. Yoga adherence studies. Altern Ther Health Med. 2009;15:36–42.
